Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Surgical Oncology
- Vol. 1 (1) , 87-95
- https://doi.org/10.1016/0960-7404(92)90061-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Adjuvant Therapy of Colorectal CancerPublished by American Medical Association (AMA) ,1988
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: Results after 5 years observation timeBritish Journal of Surgery, 1985
- Adjuvant Therapy of Colon Cancer — Results of a Prospectively Randomized TrialNew England Journal of Medicine, 1984
- Adjuvant Chemotherapy in Cancer of the Colon and Rectum: Demonstration of Effectiveness of Prolonged 5-FU Chemotherapy in a Prospectively Controlled, Randomized TrialSurgical Clinics of North America, 1981
- Adjuvant chemotherapy in the surgical treatment of large bowel cancerCancer, 1976
- A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinomaCancer, 1975
- Fudr as an adjuvant to surgery in cancer of the large bowelJournal of Surgical Oncology, 1973